Skip to content

Clinical trials

Fibrosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: Canada Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20081
20094
20104
20112
20122
20136
201410
20155
20164
20175
20181
20191
20201
20214
20223
20231
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated10
Recruiting5
Active, not recruiting4
Unknown status3
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences9
University of Alberta5
Intercept Pharmaceuticals4
AbbVie3
Centre hospitalier de l'Université de Montréal (CHUM)3
McGill University Health Centre/Research Institute of the McGill University Health Centre3
University Health Network, Toronto3
Vertex Pharmaceuticals Incorporated3
89bio, Inc.2
Celgene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis67
Non-alcoholic Fatty Liver Disease12
Hepatitis C11
Ascites6
Fatty Liver6
Digestive System Diseases5
Idiopathic Pulmonary Fibrosis5
Liver Diseases5
Lung Diseases5
Hepatitis C, Chronic4

Trials

Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.